Thorsten Klampfl

4.0k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

Thorsten Klampfl is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Thorsten Klampfl has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 12 papers in Hematology and 9 papers in Molecular Biology. Recurrent topics in Thorsten Klampfl's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Thorsten Klampfl is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Thorsten Klampfl collaborates with scholars based in Austria, Italy and Germany. Thorsten Klampfl's co-authors include Róbert Královics, Daniela Pietra, Mario Cazzola, Ashot S. Harutyunyan, Elisa Rumi, Tiina Berg, Chiara Elena, Jelena D. Milosevic Feenstra, Ilaria Carola Casetti and Cristiana Pascutto and has published in prestigious journals such as Blood, PLoS ONE and Nature Chemical Biology.

In The Last Decade

Thorsten Klampfl

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

2013 391 citations Elisa Rumi, Daniela Pietra et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thorsten Klampfl Austria	11	711	682	583	240	123	20	1.1k
Matteo Molica Italy	16	253 0.4×	341 0.5×	487 0.8×	113 0.5×	54 0.4×	70	773
Maria Stella Pennisi Italy	14	294 0.4×	235 0.3×	283 0.5×	100 0.4×	136 1.1×	34	798
Lucy J. Elrick United Kingdom	10	291 0.4×	435 0.6×	587 1.0×	278 1.2×	27 0.2×	13	1.1k
Cezary Swider United States	11	522 0.7×	201 0.3×	494 0.8×	79 0.3×	191 1.6×	20	1.1k
Julie-Aurore Losman United States	10	696 1.0×	310 0.5×	260 0.4×	65 0.3×	399 3.2×	22	1.1k
P. Rae United States	6	412 0.6×	679 1.0×	984 1.7×	476 2.0×	34 0.3×	8	1.4k
Carla B. Ripamonti Italy	14	452 0.6×	146 0.2×	354 0.6×	73 0.3×	99 0.8×	29	907
Gabriele Stefanzl Austria	17	232 0.3×	223 0.3×	310 0.5×	151 0.6×	51 0.4×	38	794
J Lyons Germany	8	256 0.4×	201 0.3×	424 0.7×	48 0.2×	66 0.5×	11	775
Silvia Rita Vitale Italy	16	429 0.6×	163 0.2×	169 0.3×	75 0.3×	333 2.7×	46	978

Countries citing papers authored by Thorsten Klampfl

Since Specialization

Citations

This map shows the geographic impact of Thorsten Klampfl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Klampfl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Klampfl more than expected).

Fields of papers citing papers by Thorsten Klampfl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten Klampfl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Klampfl. The network helps show where Thorsten Klampfl may publish in the future.

Co-authorship network of co-authors of Thorsten Klampfl

This figure shows the co-authorship network connecting the top 25 collaborators of Thorsten Klampfl. A scholar is included among the top collaborators of Thorsten Klampfl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thorsten Klampfl. Thorsten Klampfl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klampfl, Thorsten, Eszter Doma, Omar Torres‐Quesada, et al.. (2025). CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia. Cell Death and Disease. 16(1). 107–107. 2 indexed citations

Doma, Eszter, Thorsten Klampfl, Michaela Prchal‐Murphy, et al.. (2024). Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells. Blood. 144(2). 156–170. 5 indexed citations

Klein, Klara R., Thorsten Klampfl, Jana Trifinopoulos, et al.. (2024). A lineage-specific STAT5B N642H mouse model to study NK-cell leukemia. Blood. 143(24). 2474–2489. 4 indexed citations

Trifinopoulos, Jana, Thorsten Klampfl, Klara R. Klein, et al.. (2024). Cyclin C promotes development and progression of B-cell acute lymphoblastic leukemia by counteracting p53-mediated stress responses. Haematologica. 110(4). 877–892.

Schmoellerl, Johannes, Reinhard Grausenburger, Eszter Doma, et al.. (2023). SBNO2 is a critical mediator of STAT3-driven hematological malignancies. Blood. 141(15). 1831–1845. 5 indexed citations

Heller, Gerwin, Markus Zojer, André C. Mueller, et al.. (2022). CDK6 Degradation Is Counteracted by p16INK4A and p18INK4C in AML. Cancers. 14(6). 1554–1554. 9 indexed citations

Grausenburger, Reinhard, Thorsten Klampfl, Michaela Prchal‐Murphy, et al.. (2021). A STAT5B–CD9 axis determines self-renewal in hematopoietic and leukemic stem cells. Blood. 138(23). 2347–2359. 26 indexed citations

Prins, Daniel, et al.. (2020). Mutant Calreticulin in the Myeloproliferative Neoplasms. HemaSphere. 4(1). e333–e333. 27 indexed citations

Nice, Francesca, Charlie E. Massie, Thorsten Klampfl, & Anthony R. Green. (2017). Determination of complex subclonal structures of hematological malignancies by multiplexed genotyping of blood progenitor colonies. Experimental Hematology. 57. 60–64.e1. 4 indexed citations

10.

Li, Juan, Daniel Prins, Hyun Jung Park, et al.. (2017). Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage. Blood. 131(6). 649–661. 57 indexed citations

11.

Winter, Georg E., Branka Radic-Sarikas, Cristina Mayor‐Ruiz, et al.. (2014). The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity. Nature Chemical Biology. 10(9). 768–773. 128 indexed citations

12.

Rumi, Elisa, Daniela Pietra, Virginia Valeria Ferretti, et al.. (2013). JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood. 123(10). 1544–1551. 391 indexed citations breakdown →

13.

Rumi, Elisa, Ashot S. Harutyunyan, Chiara Elena, et al.. (2011). Identification of genomic aberrations associated with disease transformation by means of high‐resolution SNP array analysis in patients with myeloproliferative neoplasm. American Journal of Hematology. 86(12). 974–979. 31 indexed citations

14.

Feenstra, Jelena D. Milosevic, Tiina Berg, Thorsten Klampfl, et al.. (2011). Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. American Journal of Hematology. 87(3). 245–250. 80 indexed citations

15.

Klampfl, Thorsten, Lukas F. Mager, Christine Heinzle, et al.. (2011). Up-regulation of 12(S)-lipoxygenase induces a migratory phenotype in colorectal cancer cells. Experimental Cell Research. 318(6). 768–778. 29 indexed citations

16.

Huang, Ru, Markus Jaritz, Philipp Guenzl, et al.. (2011). An RNA-Seq Strategy to Detect the Complete Coding and Non-Coding Transcriptome Including Full-Length Imprinted Macro ncRNAs. PLoS ONE. 6(11). e27288–e27288. 77 indexed citations

17.

Klampfl, Thorsten, Ashot S. Harutyunyan, Tiina Berg, et al.. (2011). Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression. Blood. 118(1). 167–176. 128 indexed citations

18.

Jäger, Roland, Heinz Gisslinger, Francesco Passamonti, et al.. (2010). Deletions of the transcription factor Ikaros in myeloproliferative neoplasms. Leukemia. 24(7). 1290–1298. 105 indexed citations

19.

Klampfl, Thorsten, Ashot S. Harutyunyan, Tiina Berg, et al.. (2010). Chromosomal Aberration Network In Myeloproliferative Neoplasms. Blood. 116(21). 318–318. 3 indexed citations

20.

Jäger, Roland, Heinz Gisslinger, Tiina Berg, et al.. (2009). Deletions of the Transcription Factor Ikaros in Myeloproliferative Neoplasms at Transformation to Acute Myeloid Leukemia.. Blood. 114(22). 435–435. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact